P399 Higher anti-tumour necrosis factor-alpha drug levels are associated with improved radiological outcomes in patients with perianal fistulising Crohn’s disease: A retrospective multi-centre study

Michael De Gregorio(The University of Melbourne), Nik S. Ding(The University of Melbourne), Ashish Srinivasan(Eastern Health), Peter De Cruz(The University of Melbourne), Matthew Bastian‐Jordan(The University of Queensland), Nira Borok(Liverpool Hospital), Bonita Gu(Royal Prince Alfred Hospital), T Lee(St Vincent's Hospital Melbourne), Daniel R. van Langenberg(Eastern Health), C. Welman(Fiona Stanley Hospital), Gregory Amos(The University of Queensland), Gillian Mahy(Townsville Hospital), Lena Thin(The University of Western Australia), Robert Gilmore(The University of Queensland), A Lee(Peter MacCallum Cancer Centre), Susan J. Connor(Liverpool Hospital), Dougal Brown(Townsville Hospital), Eric Yong(St Vincent's Hospital Melbourne), Numan Kutaiba(Eastern Health), Jakob Begun(Translational Research Institute), Lauren E. Gilbert(Alfred Health), Yoon‐Kyo An(Mater Hospital), Krupa Krishnaprasad(QIMR Berghofer Medical Research Institute), M Sparrow co-lead senior author(Alfred Health), Alexander Thompson(The University of Melbourne), Wa Cheung(Alfred Health), JF Gerstenmaier(Alfred Health)
Journal of Crohn s and Colitis
May 1, 2021
Cited by 0


Related Papers